Skip to main content

Advertisement

Log in

A simple two-strip method to determine the radiochemical purity of technetium-99m mercaptoacetyltriglycine

  • Original Article
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Technetium-99m mercaptoacetyltriglycine (MAG3) has been used extensively as a renal function agent for several years. Radioimpurities in the MAG3 kit preparation are not only concentrated and excreted in the kidneys. Therefore proper quality control for renal studies is even more important to make possible a rapid and adequate interpretation of diagnostic studies. The standard method to determine the radiochemical purity is high-performance liquid chromatography (HPLC), which is time consuming and expensive. We set up a new simple thin-layer chromatography (TLC) method based on instant thin-layer silica gel strips as statitionary phase for checking the main impurities, free pertechnetate and reduced hydrolysed 99mTc-colloid. Comparison of TLC and HPLC results showed no significant differences (t-test, P<0.05); the correlation between the results obtained with the two methods in respect of the free pertechnetate content was excellent (r=0.99913). The TLC method was also efficient in determining the percentage of 99mTc-colloid. The main impurity found in 37 routine preparations was free pertechnetate; the mean radiochemical purity was 97.95%. The time required to perform the analysis was less than 20 min. The new TLC system is a cheap, simple, fast, reliable and accurate method for the quality control of the MAG3 kit preparation, and is especially suitable for routine use.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fritzberg AR, Kasina S, Eshima D, Johnson DL. Synthesis and biological evaluation of 99mTc-MAG3 as a hippuran replacement. J Nucl Med 1986; 27:111–116

    Google Scholar 

  2. Britton KE, Al-Nahas AA, Jafri RA, Bomanji I, Solanki K, Carrol MJ, Nimmon CC. Tc-99m MAG3: a routine renal radiopharmaceutical [abstract]. J Nucl Med 1989; 30:1Ab-2Ab.

    Google Scholar 

  3. Taylor A Jr, Fritzberg AR, Eshima D. The development and characterization of Tc-99m mercaptoacetyltriglycine (MAG3). In: Maddalena DJ, Snowdon GM, Boniface GR, eds. Advances in radiopharmacology, proceedings of the sixth international symposium on radiopharmacology 1989; 58–69

  4. Package insert for Technescan MAG3. Mallinckrodt Medical B. V. Petten, Holland, No. 1991

  5. Crombez D, Van Nerom C, Bormans G, De Roo M, Verbruggen A. Comparison of purity and biological behavior in mice of kit-formulated and HPLC-purified Tc-99m MAG3. In: Schmidt HAE, Van der Schoot JE, eds. Proceedings of the third congress of the European Association of Nuclear Medicine, Amsterdam 1990. Stuttgart: Schattauer; 1991:127

    Google Scholar 

  6. Taylor A Jr, Eshima D, Christian PE, Wooten WW, Hansen L, McElvany K. Technetium-99m MAG3 kit formulation: preliminary results in normal volunteers and patients with renal failure. J Nucl Med 1988; 29:616–622.

    Google Scholar 

  7. Brandau W, Bubeck B, Eisenhut M, Taylor DM. Technetium 99m labelled renal function and imaging agents III; synthesis of MAG3 and biodistribution of byproducts. Appl Radiat Isot 1988;39:121–129.

    Google Scholar 

  8. Millar AM. Quality assurance of radiopharmaceuticals. In: Theobald AE, ed. Radiopharmaceuticals and radiotracers in pharmacy. Chichester: Ellis Horwood; 1989

    Google Scholar 

  9. Convency JR, Robbins MS. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats. J Nucl Med 1987; 28:1881–1887.

    Google Scholar 

  10. Bagni B, Marzocchi S, Cavallini AR. MAG-3 quality control: a new method. Preliminary experience. In: Radioactive isotopes in clinical medicine and research, 20th Badgastein Symposium. January 1992 (abstract programme)

  11. Package insert for Technescan MAG3 June. Mallinckrodt Medican Inc., St. louis, Mo, 1990

  12. Chen F, Zhou Q. Preparation of a new renal function imaging agent kit of Tc-99m-MAG3 and its preliminary clinical application. Chin J Nucl Med 1990; 10:27

    Google Scholar 

  13. Fueger G. Qualitätskontrolle durch die Nutzer. In: Qualitätskontrolle II — Radiopharmaka Fortbildungstagung für das technische Personal an Nuklearmedizinischen Stationen, Linz, 1992

  14. Nunn AD, Fritzberg AR. Components for the design of a radio-HPLC system. In: Wieland DM, Tobes MC, Mangner TJ, eds. Analytical and chromatographic techniques in radiopharmaceutical chemistry. Berlin Heidelberg New York: Springer 1986; 103–124

    Google Scholar 

  15. Theobald AE. Quality control of radiopharmaceuticals. In: Sampson CB, ed. Textbook of radiopharmacy: theory and practice. Gordon and Breach 1990; 115–148

Download references

Author information

Authors and Affiliations

Authors

Additional information

Correspondence to: G. Riccabona

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, F., Decristoforo, C., Rohrbacher, B. et al. A simple two-strip method to determine the radiochemical purity of technetium-99m mercaptoacetyltriglycine. Eur J Nucl Med 20, 334–338 (1993). https://doi.org/10.1007/BF00169810

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00169810

Key words

Navigation